Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

被引:369
|
作者
Zheng, YH
Irwin, D
Kurosu, T
Tokunaga, K
Sata, T
Peterlin, BM
机构
[1] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Microbiol & Immunol, Rosalind Russell Med Res Ctr, San Francisco, CA 94143 USA
[3] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan
关键词
D O I
10.1128/JVI.78.11.6073-6076.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recently, APOBEC3G has been identified as a host factor that blocks retroviral replication. It introduces G to A hypermutations in newly synthesized minus strand viral cDNA at the step of reverse transcription in target cells. Here, we identified the human APOBEC3F protein as another host factor that blocks human immunodeficiency virus type 1 (HIV-1) replication. Similar to APOBEC3G, APOBEC3F also induced G to A hypermutations in HIV genomic DNA, and the viral Vif protein counteracted its activity. Thus, APOBEC family members might have evolved as a general defense mechanism of the body against retroviruses, retrotransposons, and other mobile genetic elements.
引用
收藏
页码:6073 / 6076
页数:4
相关论文
共 50 条
  • [1] Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles
    Wang, Xin
    Li, Xiaoyu
    Ma, Jing
    Zhang, Li
    Ma, Ling
    Mi, Zeyun
    Zhou, Jinming
    Guo, Fei
    Kleiman, Lawrence
    Cen, Shan
    VIRUS RESEARCH, 2014, 191 : 30 - 38
  • [2] Genetic Analysis of the Localization of APOBEC3F to Human Immunodeficiency Virus Type 1 Virion Cores
    Donahue, John P.
    Levinson, Rebecca T.
    Sheehan, Jonathan H.
    Sutton, Lorraine
    Taylor, Harry E.
    Meiler, Jens
    D'Aquila, Richard T.
    Song, Chisu
    JOURNAL OF VIROLOGY, 2015, 89 (04) : 2415 - 2424
  • [3] Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F
    Ulenga, Nzovu K.
    Sarr, Abdoulaye Dieng
    Thakore-Meloni, Seema
    Sankale, Jean-Louis
    Eisen, Geoff
    Kanki, Phyllis J.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (04): : 486 - 492
  • [4] Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F
    Russell, Rebecca A.
    Pathak, Vinay K.
    JOURNAL OF VIROLOGY, 2007, 81 (15) : 8201 - 8210
  • [5] Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif
    Russell, Rebecca A.
    Smith, Jessica
    Barr, Rebekah
    Bhattacharyya, Darshana
    Pathak, Vinay K.
    JOURNAL OF VIROLOGY, 2009, 83 (04) : 1992 - 2003
  • [6] Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F
    Tian, CJ
    Yu, XH
    Zhang, W
    Wang, T
    Xu, RZ
    Yu, XF
    JOURNAL OF VIROLOGY, 2006, 80 (06) : 3112 - 3115
  • [7] Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation
    Luo, Kun
    Wang, Tao
    Liu, Bindong
    Tian, Chunjuan
    Xiao, Zuoxiang
    Kappes, John
    Yu, Xiao-Fang
    JOURNAL OF VIROLOGY, 2007, 81 (13) : 7238 - 7248
  • [8] Long-Term Restriction by APOBEC3F Selects Human Immunodeficiency Virus Type 1 Variants with Restored Vif Function
    Albin, John S.
    Hache, Guylaine
    Hultquist, Judd F.
    Brown, William L.
    Harris, Reuben S.
    JOURNAL OF VIROLOGY, 2010, 84 (19) : 10209 - 10219
  • [9] Moderate Influence of Human APOBEC3F on HIV-1 Replication in Primary Lymphocytes
    Mulder, Lubbertus C. F.
    Ooms, Marcel
    Majdak, Susan
    Smedresman, Jordan
    Linscheid, Caitlin
    Harari, Ariana
    Kunz, Andrea
    Simon, Viviana
    JOURNAL OF VIROLOGY, 2010, 84 (18) : 9613 - 9617
  • [10] Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus
    Albin, John S.
    Brown, William L.
    Harris, Reuben S.
    VIROLOGY, 2014, 450 : 49 - 54